Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy

NCT04978987 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT04978987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04978987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Disease Specific Pathways and Modifiers in Phospholamban R14del Cardiomyopathy
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
November 1, 2020
Completion date
May 1, 2023
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy, familial, heart failure, phospholamban r14del cardiomyopathy